These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2512960)

  • 1. Follow-up study of soluble interleukin-2 receptor serum levels in non-progressing HIV-infected people.
    Lang JM; Levy S; Coumaros G; Lehr L; Partisani M; Dossou-Gbete V; Steckmeyer M; Koehl C
    AIDS; 1989 Oct; 3(10):673-4. PubMed ID: 2512960
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
    Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.
    Longo G; Natoli C; Rafanelli D; Tinari N; Morfini M; Rossi-Ferrini P; D'Ostilio N; Iacobelli S
    Br J Haematol; 1993 Sep; 85(1):207-9. PubMed ID: 8251396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble interleukin-2 receptor in patients with primary nephrotic syndrome.
    Ayli MD; Duman N; Duranay M; Ateş K; Ayli M; Karatan O; Erbay B; Ertuğ E
    Nephron; 1998 Nov; 80(3):349-50. PubMed ID: 9807046
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated serum levels of soluble interleukin-2 receptor in juvenile dermatomyositis.
    Kobayashi I; Ono S; Kawamura N; Okano M; Kobayashi K
    Pediatr Int; 2001 Feb; 43(1):109-11. PubMed ID: 11208016
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.
    Fortis C; Soldini L; Ghezzi S; Colombo S; Tambussi G; Vicenzi E; Gianotti N; Nozza S; Veglia F; Murone M; Lazzarin A; Poli G
    AIDS Res Hum Retroviruses; 2002 May; 18(7):491-9. PubMed ID: 12015902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of soluble interleukin-2 receptor.
    Chrobák L
    Acta Medica (Hradec Kralove); 1996; 39(1):3-6. PubMed ID: 9106384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
    Tomita N; Taguri M; Hashimoto C; Takasaki H; Fujimaki K; Motomura S; Koharazawa H; Takemura S; Fujita H; Yamazaki E; Kawasaki R; Taguchi J; Sakai R; Fujisawa S; Hattori Y; Kanamori H; Yamamoto W; Harano H; Ogawa K; Ishigatsubo Y
    Ann Hematol; 2015 Nov; 94(11):1935-7. PubMed ID: 26208667
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients.
    Sipsas NV; Sfikakis PP; Touloumi G; Pantazis N; Choremi H; Kordossis T
    AIDS Patient Care STDS; 2003 Apr; 17(4):147-53. PubMed ID: 12737638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-2 receptor in children with reflux nephropathy.
    Konda R; Sakai K; Ota S; Takeda A; Chida N; Sato H; Orikasa S
    J Urol; 1998 Feb; 159(2):535-9. PubMed ID: 9649287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study Group.
    Staszewski S; Miller V; Kober A; Colebunders R; Vandercam B; Delescluse J; Clumeck N; Van Wanzeele F; De Brabander M; De Creé J; Moeremans M; Andries K; Boucher C; Stoffels P; Janssen PA
    Antivir Ther; 1996 Jan; 1(1):42-50. PubMed ID: 11322258
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum soluble interleukin 2 receptor in patients with IgA nephropathy.
    Yorioka N; Hirabayashi A; Takemasa A; Kanahara K; Takahashi N; Oda H; Joarder ZH; Harada S; Yamakido M
    Hiroshima J Med Sci; 1989 Dec; 38(4):169-71. PubMed ID: 2637244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum soluble CD8 and soluble interleukin-2-receptor levels during interferon therapy in chronic hepatitis C].
    Maekawa H; Ishiyama N; Furuya N; Nakahara K; Saito S; Uchimura H
    Rinsho Byori; 1997 Oct; 45(10):1003-7. PubMed ID: 9369080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic hypereosinophilic syndrome associated with elevated plasma levels of interleukin-10 and soluble interleukin-2 receptor.
    Kanbe N; Kurosawa M; Igarashi N; Tamura A; Yamashita T; Kurimoto F; Miyachi Y
    Br J Dermatol; 1998 Nov; 139(5):916-8. PubMed ID: 9892967
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases.
    Honda M; Kitamura K; Mizutani Y; Oishi M; Arai M; Okura T; Igarahi K; Yasukawa K; Hirano T; Kishimoto T
    J Immunol; 1990 Dec; 145(12):4059-64. PubMed ID: 2258606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum human leukocyte antigen-G and soluble interleukin 2 receptor levels in acute lymphoblastic leukemic pediatric patients.
    Motawi TM; Zakhary NI; Salman TM; Tadros SA
    Asian Pac J Cancer Prev; 2012; 13(11):5399-403. PubMed ID: 23317190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of soluble interleukin-2 receptor--a possible index of disease prognosis in systemic sclerosis.
    Lis A; Brzezińska-Wcisło L; Rubisz-Brzezińska J; Kulawik I
    Clin Exp Dermatol; 1997 Jan; 22(1):60-1. PubMed ID: 9330064
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection.
    Tülek N; Saglam SK; Saglam M; Türkyilmaz R; Yildiz M
    Hepatogastroenterology; 2000; 47(33):828-31. PubMed ID: 10919040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.